Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration

Nephrol Dial Transplant. 1989;4(7):635-9.

Abstract

Vancomycin is widely used for the treatment of infections with Gram-positive bacteria in patients with end-stage renal disease. The concentration of vancomycin in serum, in ultrafiltrate, and in dialysate was measured during nine haemofiltration and seven haemodialysis procedures with high-permeability membranes. The t1/2 of vancomycin was 101 +/- 19 h in the interdialytic and interhaemofiltration period. There was no significant difference between the haemodialysis clearance (55.2 +/- 18.5 ml/min) and the haemofiltration clearance (66.8 +/- 13.6 ml/min). The redistribution phenomenon was about 25% in the post haemofiltration period and only 10% in the post haemodialysis period. Approximately 270 mg of vancomycin was recovered in dialysate or ultrafiltrate. With high-permeability membranes more commonly used in patients with end-stage renal disease, continuous monitoring of vancomycin therapy is recommended.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bacterial Infections / complications
  • Bacterial Infections / drug therapy
  • Bacterial Infections / metabolism
  • Female
  • Hemofiltration*
  • Humans
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / metabolism
  • Kidney Failure, Chronic / therapy
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Renal Dialysis*
  • Vancomycin / blood
  • Vancomycin / pharmacokinetics*
  • Vancomycin / therapeutic use

Substances

  • Vancomycin